Abreos is pioneering personalized dosing for #biologics to ensure that the right patients get the right drug at the right dose.
San Diego, CA
Joined May 2015
- Tweets207
- Following660
- Followers289
- Likes180
Pinned Tweet
At Abreos Biosciences, we want the Right Drug for the Right Patient at the Right Amount youtube.com/watch?v=1xi5Ypqt… #MedTechInnovator
Abreos Biosciences enters research collaboration with the FDA’s Center for Drug Evaluation and Research (CDER) story.cd/AALNHo
Announcing partnership with ResearchDx, a CLIA approved, CAP accredited companion diagnostics organization based in Irvine, CA to help design and develop products using Abreos' patented Veritope technology! story.cd/AAJ3XI
2
Thank you to @MSNewsToday for sharing @AbreosBio's exciting launch of our FDA-cleared LDT for the drug monitoring of #Tysabri!!
New Post: Test to Monitor Tysabri Levels in RMS Patients, moNATor by Abreos Biosciences, Now Available in US buff.ly/2P7xlao
4
See what #MultipleSclerosis doctors are saying about #moNATor: “...recent data regarding #Tysabri dosing interval extension and PML risk reduction is a major advance. The moNATor assay provides another tool to the clinician which may help to optimize patient care” -Dr. John Foley
2
So excited to be announcing the launch of our first commercial product! Available TODAY! Order your Tysabri laboratory diagnostic test at abreos.com story.cd/AAJze6
If you are a #MultipleSclerosis patient on Tysabri, take the guessing game out of dosing regimen with #moNATor, launching NEXT WEEK! Go to abreosbio.com to pre-order your drug monitoring kit now.
The commercial availability of #moNATor is ever so important given recent @BiogenMS announcements showing a significant reduction in #PML risk for patients on extended interval dosing (EID). Follow @AbreosBio for the latest updates on our product launch and #MultipleSclerosis
We are launching a laboratory developed test for precision dose monitoring of Natalizumab (#Tysabri)! Our novel assay addresses the substantial unmet need for physicians to more effectively monitor biologic drug levels in patients with #MultipleSclerosis #PML #PrecisionMedicine
Abreos Biosciences retweeted
Are you at #AAN2018? Stop by and visit #SpringboardAccelerator grad @AbreosBio (Booth #1260)! #MadeInSanDiego #Neurology xitter.cf/AbreosBio/status/98745…
Attending #AAN2018? Come by and visit us at booth #1260! We'll be giving out a sweet surprise to the first visitors... Exhibitor hours start Sunday, April 22nd at 11:30 AM. @AANMember #Neurology
There once was a company in LA
Giving out something sweet during the day
Twas only a few
Come one, come all and view
Booth #1260 today!
@AANMember @TheCravory #AAN2018 #Neurology
Attending #AAN2018? Come by and visit us at booth #1260! We'll be giving out a sweet surprise to the first visitors... Exhibitor hours start Sunday, April 22nd at 11:30 AM. @AANMember #Neurology
Attending AAN? Come by and visit us at booth #1260! We'll be giving out a sweet surprise to the first visitors... Exhibitor hours start Sunday, April 22nd at 11:30 AM.
1
Abreos Biosciences retweeted
Biocom member @AbreosBio (winner of our 2016 Five in 5 challenge) presents on their mission to become the trusted source for biologic drug monitoring & create value for all healthcare stakeholders by ensuring that patients have the right drug at the right dose #BiocomPartnering
Abreos Biosciences retweeted
Don’t miss our last round of company presentations from @AmarantusBio, Histogen, @AbreosBio, Denovo Biopharma, MDI Therapeutics, and @rapidnovor. The first session starts in 5 minutes! #BiocomPartnering
"...when the extended dosing regimens were applied, with risk reduction for PML as high as 94 percent."
1
Extending Dosing Intervals Reduces Deadly Side Effect Risk from Popular Multiple Sclerosis Drug #PrecisionMedicine #MultipleSclerosis nyulangone.org/press-release…
1
1
Abreos Biosciences retweeted
Congratulations to the @AbreosBio team - Zen is so proud to be working with you to enable dose monitoring of biologics for the masses! @PMWCintl #PrecisionMedicine #PMWC18 xitter.cf/AbreosBio/status/95627…
Proud to announce that Abreos was selected as the winner of the #PMWC18 Silicon Valley Most Promising Company Award! Thank you to all that attended the event, we are excited to bring important #PrecisionMedicine technologies to patients.
Proud to announce that Abreos was selected as the winner of the #PMWC18 Silicon Valley Most Promising Company Award! Thank you to all that attended the event, we are excited to bring important #PrecisionMedicine technologies to patients.
Abreos Biosciences retweeted
3 days to apply! Seeking the best device, diagnostic, or digital companies in the world to compete for $500K+ in cash prizes in the medtech industry's premiere accelerator. Founder friendly. No equity or participation fee. Apply now: medtechinnovator.org/apply
Abreos Biosciences retweeted
Big congrats to @AbreosBio for winning the #PrecisionMedicine #PMWC18 Silicon Valley Most Promising Company Award. @MedTechAwards 2017 finalist doing great things for patients! xitter.cf/PMWCintl/status/956204…
Abreos Biosciences & Immusoft win the #PMWC18 Silicon Valley Most Promising Company Award. Congratulations to both companies! Learn more about @AbreosBio at ow.ly/HP1930hYyOA and @immusoft at ow.ly/frlp30hYyPp #precisionmedicine #startups
